IMMURON LIMITED Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement
IMMURON LIMITED (IMRN) had Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement of 300000000.00% as of 2025-06-30, per its 20-F filed 2025-09-25.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement · last filed 2025-09-25
- 2025-06-30: Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement 300000000.00%.
- 2024-06-30: Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement 100000000.00%; Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement as first filed 200000000.00%.
- 2022-06-30: Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement 293000000.00%.
| Period end | Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement | Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement as first filed |
|---|---|---|
| 2025-06-30 | 300000000.00% 20-F · filed 2025-09-25 | |
| 2024-06-30 | 100000000.00% 20-F · filed 2025-09-25 | 200000000.00% 20-F · filed 2024-10-01 |
| 2022-06-30 | 293000000.00% 20-F · filed 2024-10-01 |